Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
Phase Holographic Imaging Announces Next Generation HoloMonitor
Phase Holographic Imaging (PHI) is pleased to announce that the next generation of PHI’s live cell imaging system enters its final development stage. The new model is currently undergoing pre-production testing both internally and externally at the Huntsman Cancer Institute and Wake Forest Institute of Regenerative Medicine.
Phase Holographic Imaging Announces Management Changes
Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development that lies ahead.
PHI announces last day of trading in BTA
Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ) 8 January 2025
Phase Holographic Imaging PHI AB (publ), held a general meeting on 8 January 2025. The following resolutions were made.
PHI announces outcome of rights issue
Founder and board member subscribes for shares in the ongoing rights issue
Peter Egelberg, founder and Board member of Phase Holographic Imaging PHI AB has notified the Company that he, together with closely related parties, follows Altium SA’s lead by subscribing for shares in the Company’s ongoing fully secured rights issue. The subscription amounts to approximately 300 TSEK.
PHI at Aktieportföljen Live, BioStock and Financial Stockholm
The subscription period in PHI AB’s fully secured rights issue, totalling SEK 64.3 million, is ongoing until 20 December 2024. The Company’s CEO, Anders Månsson, has during the last couple of weeks presented the Company and its future plans. For links to the presentations and the podcast, see below.
Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ) 8 January 2025
The shareholders of Phase Holographic Imaging PHI AB (publ), (“the Company”), reg.no. 556542-7811, are hereby invited to attend the general meeting on 8 January 2025 at 15.00 at the Company´s office at Skiffervägen 48 in Lund.